Le Pichon, C. E., Dominguez, S. L., Solanoy, H., Ngu, H., Lewin-Koh, N., Chen, M., . . . Scearce-Levie, K. (2013). EGFR Inhibitor Erlotinib Delays Disease Progression but Does Not Extend Survival in the SOD1 Mouse Model of ALS. Public Library of Science.
Citação norma ChicagoLe Pichon, Claire E., Sara L. Dominguez, Hilda Solanoy, Hai Ngu, Nicholas Lewin-Koh, Mark Chen, Jeffrey Eastham-Anderson, Ryan Watts, and Kimberly Scearce-Levie. EGFR Inhibitor Erlotinib Delays Disease Progression but Does Not Extend Survival in the SOD1 Mouse Model of ALS. Public Library of Science, 2013.
ציטוט MLALe Pichon, Claire E., et al. EGFR Inhibitor Erlotinib Delays Disease Progression but Does Not Extend Survival in the SOD1 Mouse Model of ALS. Public Library of Science, 2013.